Investor Relations

Press Release

November 2, 2018

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018

More
August 29, 2018

Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference 2018

More
August 8, 2018

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2018

More
August 3, 2018

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2018

More
July 9, 2018

Amphastar Announces Expansion of Amphastar Nanjing Pharmaceuticals Inc.

More
June 19, 2018

Amphastar Announces Approval for Isoproterenol Hydrochloride Injection, USP

More
June 4, 2018

Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference 2018

More
June 4, 2018

Amphastar Pharmaceuticals Receives FDA Approval for Semi-Purified Heparin at Amphastar Nanjing Pharmaceuticals

More
May 14, 2018

Amphastar Pharmaceuticals Receives FDA Approval for Calcium Chloride Injection

More
May 10, 2018

Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2018

More
Youtube